Non-alcoholic fatty liver disease (NAFLD) is a chronic non-communicable disease, with a prevalence of 25% worldwide. This pathology is a multifactorial illness, and is associated with different risks factors, including hypertension, hyperglycemia, dyslipidemia, and obesity. Beside these predisposing features, NAFLD has been related to changes in the microbiota, which favor the disease progression. In this context, the modulation of the gut microbiota has emerged as a new therapeutic target for the prophylaxis and treatment of NAFLD. This review describes the changes in the gut microbiota associated with NAFLD and the effect of probiotics, prebiotics, and synbiotics on the gut microbiota, liver damage, anthropometric parameters, blood lipids, inflammation markers and insulin resistance in these patients. © 2021 by the authors. Licensee MDPI, Basel, Switzerland.
Skip Nav Destination
Review|
March 24 2022
Probiotics and prebiotics as a strategy for non-alcoholic fatty liver disease, a narrative review.
C. Ibacache-Quiroga, Escuela de Nutricion y Dietetica, Facultad de Farmacia, Universidad de Valparaiso, Valparaiso 2360102, Chile. E-mail claudia.ibacache@uv.cl
Journal: Foods
Citation: Foods (2022) 10 (8)
DOI: 10.3390/foods10081719
Published: 2021
Citation
Castillo, V., Figueroa, F., Gonzalez-Pizarro, K., Jopia, P., Ibacache-Quiroga, C.; Probiotics and prebiotics as a strategy for non-alcoholic fatty liver disease, a narrative review.. IFIS Food and Health Sciences Database 2022; doi:
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Sign in via your Institution
Sign in via your Institution
Analyse Trends
Explore publication trends in the sciences of food and health.
Discover and compare the use of keywords over time.
Find global trends in research through publication categories.